According to recent insights from Future Market Insights, the global pharmaceutical lactose market is projected to reach USD 222.6 million in 2023, with a compound annual growth rate (CAGR) of 5.8% over the forecast period from 2023 to 2033. By 2033, the market is expected to attain a valuation of USD 392.3 million.
The growth of the pharmaceutical lactose market is driven by the increasing demand for orally disintegrating tablets (ODTs), where lactose serves as an effective carrier. Additionally, lactose’s biocompatibility and biodegradability make it an attractive option for various drug delivery systems. With the pharmaceutical industry focusing on patient-centric formulations, lactose plays a crucial role in improving the taste, texture, and stability of oral medications, thus enhancing patient compliance.
The growing use of lactose as a key excipient in the expanding pharmaceutical sector is a major factor fueling market growth. Additionally, the rising prevalence of chronic diseases, the development of new medications, and heightened investment in research and development are expected to drive the continued expansion of the global pharmaceutical lactose market.
Over the years, lactose has become one of the most commonly used excipients in the pharmaceutical sector for producing a wide range of solid dosage forms. It finds application as a binder, carrier, or diluent and helps pharmaceutical companies to produce tablets of sufficient hardness.
Rising production and consumption of solid dosage forms such as capsules and tablets is expected to boost pharmaceutical lactose demand during the forecast period. Subsequently, growing demand for dry powder inhalation products will create growth opportunities for pharmaceutical lactose manufacturers.
Various forms of lactose i.e., α-lactose monohydrate, β-lactose, amorphous lactose, and spray dried lactose are being employed for manufacturing drugs.
Increasing healthcare awareness, especially across developing regions, growing popularity of preventive healthcare, and rising healthcare spending are expected to further expand the pharmaceutical lactose Industry size over the next ten years.
Request Report Sample: https://www.fmisamplereport.com/sample/rep-gb-8756
Key Takeaways from the Pharmaceutical Lactose Market Study:
- Pharmaceutical lactose market is projected to surge at a CAGR of about 8% over the next ten years in Mexico.
- By product type, α-lactose monohydrate segment will continue to lead the global pharmaceutical lactose Industry during the forecast period.
- The United Kingdom pharmaceutical lactose market is anticipated to exceed a valuation of US$ 184.8 million by 2033.
- The USA is anticipated to hold around 78.3% share of North America pharmaceutical lactose market in 2023.
- Mexico is poised to hold around 5.3% of the global pharmaceutical lactose market by 2033.
Who is Winning?
DFE Pharma, Ba’emek Advanced Technologies Ltd (Tnuva Group), Avantor, Inc., Alpavit Käserei Champignon Hofmeister GmbH & Co. KG, Lactose (India) Limited, Hoogwegt Groep B.V., Hilmar Ingredients, Armor Pharma, Merck KgaA, Kerry plc, Milei GmbH, BASF SE, MEGGLE Excipients & Technology are few of the leading companies present in the global pharmaceutical lactose market.
Key pharmaceutical lactose companies are focusing on partnerships and joint ventures to expand their product portfolio and strengthen their supply chain.
Get Valuable Insights into Pharmaceutical Lactose Market
Future Market Insights, in its new offering, provides an unbiased analysis of the pharmaceutical lactose Industry presenting historical demand data (2018 to 2022) and forecast statistics for the period from (2023 to 2033). The study divulges compelling insights on the demand based on product type (β-Lactose, α-Lactose monohydrate, Amorphous lactose, Spray dried lactose) and region.
About the Food & Beverage Division at Future Market Insights
Expert analysis, actionable insights, and strategic recommendations- the food & beverage team at Future Market Insights helps clients from all over the globe with their unique business intelligence needs. With a repertoire of over 1,000 reports and 1 million+ data points, the team has analyzed the food & beverage industry lucidly in 50+ countries for over a decade. The team provides end-to-end research and consulting services; reach out to explore how we can help.
Pharmaceutical Lactose Market by Category
Product Type:
- β-lactose
- α-Lactose monohydrate
- Amorphous Lactose
- Spray Dried Lactose
Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Middle East and Africa
- Oceania
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
